Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:48 PM
Ignite Modification Date:
2025-12-24 @ 7:48 PM
NCT ID:
NCT06651203
Eligibility Criteria:
Inclusion criteria for all patient :
* Age ≥ 18
* Patients with health insurance
* Patients informed and not opposed to the study
Inclusion criteria for group 1 :
\- Patients with clinical features consistent with erythrodermic CTCL at initial diagnosis.
Inclusion criteria for group 2 :
* Confirmed SS (previously diagnosed), followed at Saint Louis hospital participating center with all the following criteria:
1. Stage T4 erythroderma (stage (erythrodermia ≥ 80% of total body area)
2. The presence of an identical T-cell clone evidenced in blood and skin
3. B2 blood staging at initial diagnosis
Exclusion Criteria:
* Other progressive neoplastic disease
* Progressive psychotic disease
* Patient under guardianship or curatorship
* Patients with state medical aid
* Refusal to participate
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06651203
Study Brief:
Protocol Section:
NCT06651203